This report offers companies, investors, policymakers, and stakeholders crucial insight into the birthplace of the modern pharmaceutical industry; a country that has transitioned out of economic recession and is now benefiting from its prime geographic position, tradition for quality manufacturing, and concentration of expertise. It also depicts how stakeholders are attempting to tackle the challenges of pricing, regional disparity, and efficiency.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Italian healthcare and pharma sectors.